A systemic gentamicin pathway across the stria vascularis

Chun Fu Dai,Peter S. Steyger
DOI: https://doi.org/10.1016/j.heares.2007.10.010
IF: 3.672
2008-01-01
Hearing Research
Abstract:The mechanism(s) by which systemically-administered aminoglycosides enter the cochlea remain poorly understood. To elucidate which mechanisms may be involved, we co-administered different molar ratios of gentamicin and fluorescent gentamicin (GTTR) to mice in three different regimens: (1) gentamicin (150, 300 or 600mg/kg) containing a constant 300:1 molar ratio of gentamicin:GTTR; (2) 300mg/kg gentamicin containing a variable molar ratio of gentamicin:GTTR (150:1–600:1), or (3) an increasing dose of gentamicin (150–900mg/kg), each dose containing 1.7mg/kg GTTR. Three hours later, cochleae were fixed and examined by confocal microscopy.
What problem does this paper attempt to address?